However, if accompanied by severe abdominal pain, persistent vomiting, bloody stools, or significant weight loss beyond expected therapeutic effects, medical evaluation is warranted to rule out other gastrointestinal conditions
September 1, 2025: FDA Approves Wegovy for Fatty Liver Disease The FDA has granted a new indication for Wegovy (semaglutide) to treat metabolic dysfunction-associated steatohepatitis (MASH), a serious form of fatty liver disease in adults with moderate to advanced fibrosis
Professor Alejandra Tomas Catala, lead author and Head of Section of Cell Biology and Functional Genomics in the Department of Metabolism, Digestion and Reproduction, said: Our study reveals an entirely new way in which GLP-1 receptor agonists protect pancreatic -cells
However, semaglutide also suppresses appetite by slowing the emptying of your stomach
Does Trulicity need to be refrigerated
At the beginning of 2017, I became the Medical Director at Calista, where I perform and supervise clinical procedures